SCHEMBL3575101

SCHEMBL3575101

NC(=O)Cc1cc([N+](=O)[O-])ccc1C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.59
CYP3A4 P08684 2/20 0.59
TDP1 Q9NUW8 2/20 0.59
ALOX15 P16050 1/20 0.59
KMT2A Q03164 5/20 0.50
CYP1A2 P05177 2/20 0.49
TP53 P04637 2/20 0.48
HTT P42858 1/20 0.48
MAPT P10636 3/20 0.48
MEN1 O00255 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
POLB P06746 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
GAA P10253 1/20 0.45
CTSV O60911 1/20 0.44
CTSL P07711 1/20 0.44
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
PLA2G1B P04054 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5864351 0.88 ALDH1A1 (0.55) ALDH1A1CYP3A4TDP1ALOX15KMT2A
SCHEMBL29594919 0.87 CYP1A2 (0.64) ALDH1A1CYP3A4TDP1ALOX15KMT2A
SCHEMBL2385986 0.87 CYP1A2 (0.64) ALDH1A1CYP3A4TDP1ALOX15KMT2A
SCHEMBL28068351 0.83 ALDH1A1 (0.62) ALDH1A1CYP3A4TDP1ALOX15KMT2A
SCHEMBL2557500 0.82 ALDH1A1 (0.60) ALDH1A1CYP3A4TDP1ALOX15KMT2A
SCHEMBL28428327 0.82 ALDH1A1 (0.60) ALDH1A1CYP3A4TDP1ALOX15KMT2A
SCHEMBL27882095 0.82 ALDH1A1 (0.60) ALDH1A1CYP3A4TDP1ALOX15KMT2A
SCHEMBL2008245 0.81 ALDH1A1 (0.59) ALDH1A1CYP3A4TDP1ALOX15KMT2A
SCHEMBL4002644 0.81 GAA (0.54) ALDH1A1TDP1KMT2ACYP1A2TP53
SCHEMBL28426985 0.81 ALDH1A1 (0.58) ALDH1A1CYP3A4TDP1ALOX15KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105017152-B Preparation method of 3-chloro-6-nitroisoquinoline or 3-bromine-6-nitroisoquinoline 北京六合宁远科技有限公司 2017-05-10 CN claimed
CN-105017152-A Preparation method of 3-chloro(bromo)-6-nitroisoquinoline BEIJING LIUHE NINGYUAN TECHNOLOGY CO LTD 2015-11-04 CN claimed
CN-105017152-B Preparation method of 3-chloro-6-nitroisoquinoline or 3-bromine-6-nitroisoquinoline 北京六合宁远科技有限公司 2017-05-10 CN disclosed
CN-105017152-B Preparation method of 3-chloro-6-nitroisoquinoline or 3-bromine-6-nitroisoquinoline 北京六合宁远科技有限公司 2017-05-10 CN disclosed
CN-105017152-A Preparation method of 3-chloro(bromo)-6-nitroisoquinoline BEIJING LIUHE NINGYUAN TECHNOLOGY CO LTD 2015-11-04 CN disclosed
CN-105017152-A Preparation method of 3-chloro(bromo)-6-nitroisoquinoline BEIJING LIUHE NINGYUAN TECHNOLOGY CO LTD 2015-11-04 CN disclosed
US-7713994-B2 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo,1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihyro-3 (2H)-isoquinolones and methods of use thereof WYETH LLC (US) 2010-05-11 US disclosed
US-7713994-B2 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo,1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihyro-3 (2H)-isoquinolones and methods of use thereof WYETH LLC (US) 2010-05-11 US disclosed
EP-1963273-A2 SUBSTITUTED ISOQUINOLINE-1,3(2H,4H)-DIONES, 1-THIOXO-1,4-DIHYDRO-2H-ISOQUINOLINE-3-ONES AND 1,4-DIHYDRO-3(2H)-ISOQUINOLONES AND USE THEREOF AS KINASE INHIBITORS Wyeth a Corporation of the State of Delaware (US) 2008-09-03 EP disclosed
US-20080085890-A1 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof WYETH (US) 2008-04-10 US disclosed
US-20080085890-A1 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof WYETH (US) 2008-04-10 US disclosed
WO-2007075783-A2 SUBSTITUTED ISOQUINOLINE-1,3(2H,4H)-DIONES, 1-THIOXO-1,4-DIHYDRO-2H-ISOQUINOLINE-3-ONES AND 1,4-DIHYDRO-3(2H)-ISOQUINOLONES AND USE THEREOF AS KINASE INHIBITOR WYETH (US) 2007-07-05 WO disclosed
WO-2007075783-A2 SUBSTITUTED ISOQUINOLINE-1,3(2H,4H)-DIONES, 1-THIOXO-1,4-DIHYDRO-2H-ISOQUINOLINE-3-ONES AND 1,4-DIHYDRO-3(2H)-ISOQUINOLONES AND USE THEREOF AS KINASE INHIBITOR WYETH (US) 2007-07-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085890-A1 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof SULT1E1, RECQL, HAX1 ALDH1A1 61/4885CYP3A4 375/4885TDP1 289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.